Pancreatic Cancer Research

ResearcherChiba UniversityActive in the last 2 years

Naoya Kato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5812-2818; OpenAlex author ID A5041139736. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
50
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 11

  1. Anamorelin as a Therapeutic Option for Cancer Cachexia in Advanced Pancreatic Cancer: A Case Report Demonstrating Significant Weight Gain and Quality of Life I… Last author DOI 10.2169/internalmedicine.4708-24↗
  2. Liquid biopsy of wash samples obtained via endoscopic ultrasound-guided fine-needle biopsy: Comparison with liquid biopsy of plasma in pancreatic cancer. Co-author DOI 10.1002/dc.25306↗
  3. Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemc… Co-author DOI 10.1016/j.pan.2024.07.006↗
  4. Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgrou… Co-author DOI 10.1093/jjco/hyad044↗
  5. Detection of actionable mutations in cytological specimens obtained by endoscopic ultrasound-guided fine needle aspiration with rapid onsite evaluation in panc… Co-author DOI 10.1016/j.anndiagpath.2022.152008↗
  6. Genomic profiling amplifies the utility of endoscopic ultrasound-guided fine needle biopsy by identifying clinically applicable druggable mutations in pancreat… Co-author DOI 10.1016/j.anndiagpath.2022.152016↗
  7. Analysis of circulating cell-free DNA after endoscopic ultrasound-guided fine needle aspiration in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.pan.2021.04.001↗
  8. Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer. Last author DOI 10.1093/jjco/hyaa136↗
  9. Needle tract seeding recurrence of pancreatic cancer in the gastric wall with paragastric lymph node metastasis after endoscopic ultrasound-guided fine needle … Co-author DOI 10.1186/s12876-020-1159-x↗
  10. A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers12051294↗
  11. Five Cases of Interstitial Pneumonitis Due to Gemcitabine and Nab-Paclitaxel Combination Treatment in Pancreatic Cancer Patients. Last author DOI 10.1097/mpa.0000000000001088↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroshi Ohyama · 6 shared papers, 2018–2025 · strength 0.86
  2. Rintaro Mikata · 7 shared papers, 2018–2024 · strength 0.84
  3. Masao Omata · 3 shared papers, 2022–2024 · strength 0.47
  4. Motoyasu Kan · 2 shared papers, 2021–2025 · strength 0.31
  5. Shigetsugu Takano · 3 shared papers, 2020–2021 · strength 0.30
  6. Masayuki Ohtsuka · 3 shared papers, 2020–2021 · strength 0.30
  7. Satoshi Kobayashi · 2 shared papers, 2023–2024 · strength 0.29
  8. Masafumi Ikeda · 2 shared papers, 2023–2024 · strength 0.29
  9. Keiji Sano · 2 shared papers, 2023–2024 · strength 0.29
  10. Masato Ozaka · 2 shared papers, 2023–2024 · strength 0.29
  11. Junji Furuse · 2 shared papers, 2023–2024 · strength 0.29
  12. Makoto Ueno · 2 shared papers, 2023–2024 · strength 0.29
  13. Kazuki Watabe · 1 shared paper, 2025 · strength 0.21
  14. Jun Kato · 2 shared papers, 2020–2021 · strength 0.20
  15. Hideyuki Yoshitomi · 2 shared papers, 2020 · strength 0.20
  16. Takeshi Terashima · 1 shared paper, 2024 · strength 0.17
  17. Kohei Nakachi · 1 shared paper, 2024 · strength 0.17
  18. Hiroshi Imaoka · 1 shared paper, 2024 · strength 0.17
  19. Shun Tezuka · 1 shared paper, 2024 · strength 0.17
  20. Michiaki Unno · 1 shared paper, 2024 · strength 0.17
  21. Chigusa Morizane · 1 shared paper, 2024 · strength 0.17
  22. Kentaro Sudo · 1 shared paper, 2023 · strength 0.12
  23. Satoaki Nakamura · 1 shared paper, 2023 · strength 0.12
  24. Toshio Nakagohri · 1 shared paper, 2023 · strength 0.12
  25. Nobumasa Mizuno · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.